Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Twilio (NYSE: TWLO), de infrastructuur voor klantbetrokkenheid in het AI-tijdperk, heeft zijn gebruikersconferentie SIGNAL afgetrapt met de introductie van de volgende generatie platformmogelijkheden voor het agentic-tijdperk. Conversation Memory, Conversation Orchestrator, Conversation Intelligence en Agent Connect zijn vanaf vandaag algemeen beschikbaar en zorgen er samen voor dat losse interacties worden omgezet in doorlopende, intelligente en persoonlijke ges...

SAN FRANCISCO--(BUSINESS WIRE)--A Twilio (NYSE: TWLO), a infraestrutura para o engajamento do cliente na era da IA, iniciou sua conferência de usuários, SIGNAL, revelando os recursos de sua plataforma de próxima geração para a era dos agentes. Disponíveis hoje, Conversation Memory, Conversation Orchestrator, Conversation Intelligence, e Agent Connect se combinam para transformar interações distintas em conversas contínuas, inteligentes e personalizadas entre humanos, agentes e sistemas. “A era...

COPENAGHEN, Danimarca--(BUSINESS WIRE)--iQmetrix, il sistema operativo per il commercio intelligente per le telecomunicazioni, ha annunciato oggi che esporrà, presenterà e concorrerà come sponsor bronzo all'edizione di DTW Ignite 2026 che si terrà a Copenaghen dal 23 al 25 giugno. L'azienda offrirà una dimostrazione dal vivo di prodotti a The Loft, presenterà il proprio progetto Catalyst ODA PRISM assieme a un'associazione di operatori globali e partner tecnologici e sarà presente allo stand 31...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) gab heute die endgültigen 24-Wochen-Daten aus der Phase-3-Studie TRuE-AD4 bekannt, in der die Wirksamkeit und Sicherheit von Opzelura® (Ruxolitinib)-Creme bei Erwachsenen mit mittelschwerer atopischer Dermatitis (AD) untersucht wurde, die auf topische Kortikosteroide (TCS) und topische Calcineurin-Inhibitoren (TCI) unzureichend angesprochen hatten, diese nicht vertragen hatten oder bei denen eine Kontraindikation vorlag. Diese Daten wu...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) ha anunciado hoy los datos definitivos a las 24 semanas del estudio de fase III TRuE-AD4, en el que se evaluó la eficacia y la seguridad de la crema Opzelura® (ruxolitinib) en adultos con dermatitis atópica (DA) moderada que habían presentado una respuesta insuficiente, intolerancia o contraindicación a los corticosteroides tópicos (CT) y a los inhibidores tópicos de la calcineurina (ITC). El comunicado en el idioma original es la ver...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq : INCY) a annoncé aujourd’hui les données finales à 24 semaines de l’essai de phase 3 TRuE-AD4 évaluant l’efficacité et l'innocuité de la crème Opzelura® (ruxolitinib) chez les adultes atteints de dermatite atopique modérée présentant une réponse insuffisante, une intolérance ou une contre-indication aux corticostéroïdes topiques et aux inhibiteurs topiques de la calcineurine. Ces données sont présentées aujourd’hui (résumé n° P0851) lors du...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) maakte vandaag de finale gegevens van 24 weken bekend uit de Fase 3 TRuE-AD4-studie ter beoordeling van de doeltreffendheid en de veiligheid van Opzelura® (ruxolitinib) crème bij volwassenen met matige AD (atopische dermatitis) die onvoldoende respons, intolerantie of contra-indicatie hadden voor TCSs (topische corticosteroïden) en TCIs (Topical Calcineurin Inhibitors = topische calcineurineremmers). Deze bekendmaking is officieel geldend...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) ha annunciato oggi i dati finali su 24 settimane dello studio di Fase 3 TRuE-AD4 che valuta l'efficacia e la sicurezza della crema Opzelura® (ruxolitinib) in adulti affetti da dermatite atopica (AD) moderata che avevano registrato una risposta inadeguata, intolleranza o controindicazioni ai trattamenti con corticosteroidi topici (TCS) e inibitori topici della calcineurina (TCI). Il testo originale del presente annuncio, redatto nella l...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Kodiak Gas Services, Inc. (NYSE: KGS), (“Kodiak” or the “Company”) today announced that its board of directors has declared a cash dividend of $0.49 per share of common stock for the first quarter of 2026 (the “Common Stock Dividend”). This Common Stock Dividend will be paid on May 28, 2026 to all stockholders of record as of the close of business on May 18, 2026. In conjunction with the Common Stock Dividend, Kodiak Gas Services, LLC (“Kodiak Services”),...

IRVINE, Calif.--(BUSINESS WIRE)--D.A. Davidson & Co. (“D.A. Davidson”) announced today that it served as exclusive sell-side financial advisor to IT Assist (the “Company”), a leading TeamLogic IT franchisee, to TeamLogic LLC (“TLIT”), the franchisor. Founded in 2011 and headquartered in Newtown, Pennsylvania, IT Assist is the largest TeamLogic IT franchisee providing managed IT services, cloud solutions, and cybersecurity offerings to small and mid-sized businesses. The Company was acquired...